Contact Dermatitis
📧 Sign up to get email alerts when something new happens for Contact Dermatitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2012-09-07FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product…
-
FDA approval · 2012-08-17FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)
The FDA approved a supplemental application for CLOBEX (clobetasol propionate) submitted by Galderma Laboratories to update its labeling.
-
FDA approval · 2012-08-09FDA Approved: CLOBETASOL PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for clobetasol propionate topical product (a generic) from Padagis Israel Pharmaceuticals Ltd under AN…
-
FDA approval · 2012-06-28FDA Approved: MICORT HC CREAM — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for MICORT HC CREAM (hydrocortisone acetate cream) from Legacy Pharma USA Inc., representing an appr…
-
FDA approval · 2012-01-05FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Desoximetasone (Sun Pharmaceutical Industries, Inc.). The approval updates the product's lab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-26Clinical Trial Update: A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Clinical trial assessing safety and effectiveness of Medrol for contact dermatitis in Indian patients has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2010-03-08Clinical Trial Update: Novel Topical Treatment of Hand Dermatitis (Eczema) [Phase 1]
Phase 1 study of a novel topical treatment for hand dermatitis (eczema) has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-11Clinical Trial Update: Efficacy and Tolerability of Prednisolone Acetate 0.5% Cream Versus Betamethasone Valerate 0.1% Cream in Cortisosensitive Dermatosis [Phase 3]
Phase 3 trial comparing prednisolone acetate 0.5% cream with betamethasone valerate 0.1% cream to assess efficacy and tolerability in cortic…
-
FDA label_change · 2009-06-10FDA Approved: HALOG — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for HALOG (halcinonide cream) from Sun Pharmaceutical, resulting in updated product labeling.
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation [Phase 4]
A Phase 4 trial evaluates the efficacy of glycerol, two topical steroids, and a topical immune modulator for treating contact and occupation…
-
FDA approval · 2008-09-23FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's original ANDA for topical betamethasone dipropionate, a generic corticosteroid, for inflammatory skin conditions…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis [NA]
A completed clinical trial evaluating Tetrix for relief of burning and itching in contact dermatitis lesions.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Evaluation of Tetrix Cream in the Healing of Injured Skin in Subjects With Contact Dermatitis [NA]
Clinical trial update on Tetrix Cream for healing injured skin in subjects with contact dermatitis. The study status is completed.
-
FDA approval · 2008-03-25FDA Approved: CORDRAN — Supplemental Application (INA Pharmaceutics, Inc)
The FDA approved a supplemental application for Cordran (flurandrenolide) from INA Pharmaceutics, Inc.
-
FDA approval · 2008-03-10FDA Approved: CLOBETASOL PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved an original application for a generic clobetasol propionate topical product by Padagis Israel Pharmaceuticals Ltd.
-
FDA label_change · 2007-12-12FDA Approved: DERMOTIC — Supplemental Application (Royal Pharmaceuticals)
FDA approved a supplemental application for DERMOTIC (fluocinonide acetate) submitted by Royal Pharmaceuticals, typically resulting in updat…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
FDA approved the original application for Betamethasone Dipropionate (a generic topical corticosteroid) from E. Fougera & Co., marking appro…
-
FDA approval · 2007-05-21FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a generic topical corticosteroid, Betamethasone Dipropionate, under Sun Pharmaceutical Industries' Original Application.
-
FDA approval · 2006-08-14FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.)
FDA approves a supplemental application for clobetasol propionate from E. Fougera & Co. (division of Fougera Pharmaceuticals Inc.), under th…